Boswellia serrata for pain sensitivity and pain modulation in healthy adults
Official title: Effect of Boswellia Serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers - a Randomized, Double-blind, Placebo-controlled, Cross-over Pilot Trial
Run by Medical University of Graz · NCT07109843 · Data updated 2026-11-12
Researchers will test whether Boswellia serrata extract can reduce pain sensitivity and change how the body modulates pain in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | September 24, 2025 |
| Trial ID | NCT07109843 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18 or older without chronic pain, major medical conditions, or use of excluded medications, and who are not pregnant or breastfeeding are eligible to participate.
✕Probably not a fit
People with chronic pain, renal or liver insufficiency, neurological/dermatological/cardiovascular diseases, or those taking anticoagulants, antidepressants, MAO inhibitors, CYP-modulating drugs, or St. John's Wort are excluded and would not benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, placebo-controlled crossover study in healthy volunteers comparing Boswellia serrata extract with placebo. Participants will undergo quantitative sensory testing (QST) to measure peripheral and central sensitization and descending pain inhibitory pathways before and after each treatment period. The study uses well-defined exclusion criteria to avoid confounding by chronic pain, medications, or major medical conditions. Results aim to clarify whether observed clinical analgesic effects of Boswellia are linked to changes in pain processing mechanisms.
Why it matters
Potential benefit: If successful, the findings could point to a new, well-tolerated supplement approach that helps reduce pain sensitivity and guide treatments for chronic pain.
How similar studies have gone: Several clinical studies have suggested Boswellia serrata can relieve chronic pain, but effects on central and peripheral sensitization or pain modulation in human experimental models have not been previously established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: ≥18 years Exclusion Criteria: * Not pregnant or breastfeeding * No renal or liver insufficiency * No neurological/dermatological/cardiovascular diseases * No chronic pain and/or use of analgesics * No use of anticoagulants * No use of antidepressants * No use of MAO inhibitors * No use of St. John's Wort * No use of medications affecting the CYP mechanism * No allergies to Boswellia serrata or capsaicin"
Where it's running
-
Medical University of Graz
Graz, Styria, Austria Recruiting
Study contacts
- Study coordinator: Helmar Bornemann-Cimenti, PD Dr. MD MSc MBA
- Email: helmar.bornemann@medunigraz.at
- Phone: +43 316 385 81103
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating the effects of Griffonia simplicifolia on pain and sensitization in healthy volunteers
This study is testing if a natural supplement called Griffonia simplicifolia can help reduce pain and sensitivity in healthy people.
-
Evaluating factors related to chronic pain after hysterectomy
This study is trying to find out what factors might lead to chronic pain after a hysterectomy in women, by looking at things like anxiety and how they feel about pain before and after the surgery.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.